As of December 2024 PolyPeptide Group has a market cap of NZ$1.87 Billion. This makes PolyPeptide Group the world's 5434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.